[Theray of Parkinson-syndrome with Helfo-Dopa].
D001792:Blood Platelets / Q000187:drug effects; D003404:Creatinine / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004298:Dopamine / Q000627:therapeutic use; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D008657:Metabolic Clearance Rate; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D004295:Dihydroxyphenylalanine; D003404:Creatinine; D004298:Dopamine
Therapie des Parkinson-Syndroms mit Helfo-Dopa.